Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO).

Navarria P, Minniti G, Clerici E, Tomatis S, Pinzi V, Ciammella P, Galaverni M, Amelio D, Scartoni D, Scoccianti S, Krengli M, Masini L, Draghini L, Maranzano E, Borzillo V, Muto P, Ferrarese F, Fariselli L, Livi L, Pasqualetti F, Fiorentino A, Alongi F, di Monale MB, Magrini S, Scorsetti M.

J Neurooncol. 2018 Dec 4. doi: 10.1007/s11060-018-03059-x. [Epub ahead of print]

PMID:
30515706
2.

Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK).

Combs SE, Niyazi M, Adeberg S, Bougatf N, Kaul D, Fleischmann DF, Gruen A, Fokas E, Rödel CM, Eckert F, Paulsen F, Oehlke O, Grosu AL, Seidlitz A, Lattermann A, Krause M, Baumann M, Guberina M, Stuschke M, Budach V, Belka C, Debus J, Kessel KA.

Cancer Med. 2018 May;7(5):1742-1749. doi: 10.1002/cam4.1425. Epub 2018 Mar 23.

3.

Re-Irradiation for Recurrent Gliomas: Treatment Outcomes and Prognostic Factors.

Lee J, Cho J, Chang JH, Suh CO.

Yonsei Med J. 2016 Jul;57(4):824-30. doi: 10.3349/ymj.2016.57.4.824.

4.

Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.

Palmer JD, Siglin J, Yamoah K, Dan T, Champ CE, Bar-Ad V, Werner-Wasik M, Evans JJ, Kim L, Glass J, Farrell C, Andrews DW, Shi W.

J Neurooncol. 2015 Sep;124(2):215-21. doi: 10.1007/s11060-015-1825-y. Epub 2015 May 30.

PMID:
26024653
5.

Validation of an established prognostic score after re-irradiation of recurrent glioma.

Kessel KA, Hesse J, Straube C, Zimmer C, Schmidt-Graf F, Schlegel J, Meyer B, Combs SE.

Acta Oncol. 2017 Mar;56(3):422-426. doi: 10.1080/0284186X.2016.1276621. Epub 2017 Jan 11.

PMID:
28075197
6.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
7.

Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).

Lombardi G, Pace A, Pasqualetti F, Rizzato S, Faedi M, Anghileri E, Nicolotto E, Bazzoli E, Bellu L, Villani V, Fabi A, Ferrazza P, Gurrieri L, Dall'Agata M, Eoli M, Della Puppa A, Pambuku A, D'Avella D, Berti F, Rudà R, Zagonel V.

J Neurooncol. 2015 Nov;125(2):359-67. doi: 10.1007/s11060-015-1923-x. Epub 2015 Sep 30.

PMID:
26423801
8.

Modification and optimization of an established prognostic score after re-irradiation of recurrent glioma.

Kessel KA, Hesse J, Straube C, Zimmer C, Schmidt-Graf F, Schlegel J, Meyer B, Combs SE.

PLoS One. 2017 Jul 5;12(7):e0180457. doi: 10.1371/journal.pone.0180457. eCollection 2017.

9.

Re-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvage.

Shen CJ, Kummerlowe MN, Redmond KJ, Martinez-Gutierrez JC, Usama SM, Holdhoff M, Grossman SA, Laterra JJ, Strowd RE, Kleinberg LR.

Adv Radiat Oncol. 2018 Jul 10;3(4):582-590. doi: 10.1016/j.adro.2018.06.005. eCollection 2018 Oct-Dec.

10.

[Role of radiotherapy in recurrent gliomas].

Dhermain F, de Crevoisier R, Parker F, Cioloca C, Kaliski A, Beaudre A, Lefkopoulos D, Armand JP, Haie-Meder C.

Bull Cancer. 2004 Nov;91(11):883-9. Review. French.

11.

Re-irradiation for recurrent glioma- the NCI experience in tumor control, OAR toxicity and proposal of a novel prognostic scoring system.

Krauze AV, Peters C, Cheng J, Ning H, Mackey M, Rowe L, Cooley-Zgela T, Smart DD, Camphausen K.

Radiat Oncol. 2017 Nov 29;12(1):191. doi: 10.1186/s13014-017-0930-9.

12.

Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas.

Combs SE, Bischof M, Welzel T, Hof H, Oertel S, Debus J, Schulz-Ertner D.

J Neurooncol. 2008 Sep;89(2):205-10. doi: 10.1007/s11060-008-9607-4. Epub 2008 May 7.

PMID:
18461281
13.

Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma.

Schnell O, Thorsteinsdottir J, Fleischmann DF, Lenski M, Abenhardt W, Giese A, Tonn JC, Belka C, Kreth FW, Niyazi M.

J Neurooncol. 2016 Dec;130(3):591-599. Epub 2016 Sep 6.

PMID:
27599828
14.
15.

Concurrent hyperthermia and re-irradiation for recurrent high-grade gliomas.

Heo J, Kim SH, Oh YT, Chun M, Noh OK.

Neoplasma. 2017;64(5):803-808. doi: 10.4149/neo_2017_520.

PMID:
28592133
16.
17.
18.

Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas.

Minniti G, Scaringi C, De Sanctis V, Lanzetta G, Falco T, Di Stefano D, Esposito V, Enrici RM.

J Neurooncol. 2013 Jan;111(2):187-94. doi: 10.1007/s11060-012-0999-9. Epub 2012 Nov 6.

PMID:
23129347
19.

Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation.

Combs SE, Ahmadi R, Schulz-Ertner D, Thilmann C, Debus J.

J Neurooncol. 2005 Feb;71(3):319-23.

PMID:
15735924
20.

18F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images?

Fleischmann DF, Unterrainer M, Bartenstein P, Belka C, Albert NL, Niyazi M.

J Neurooncol. 2017 Apr;132(2):277-286. doi: 10.1007/s11060-016-2366-8. Epub 2017 Jan 19.

PMID:
28102485

Supplemental Content

Support Center